Off-Label Use of Ketamine: A Challenging Drug Treatment Delivery Model With an Inherently Unfavorable Risk-Benefit Profile.

Authors :: Pai SM
Gries JM
Source :: Journal of clinical pharmacology [J Clin Pharmacol] 2022 Jan; Vol. 62 (1), pp. 10-13. Date of Electronic Publication: 2021 Dec 02.
Publication Year :: 2022

Subjects :: Anesthetics, Dissociative adverse effects
Anesthetics, Dissociative chemistry
Humans
Ketamine adverse effects
Ketamine chemistry
Risk Assessment
Anesthetics, Dissociative therapeutic use
Ketamine therapeutic use
Off-Label Use

Full Text Access

Tools